Intelligence · Clinical Pipeline
vTv Therapeutics Pipeline
All ClinicalTrials.gov programs at vTv Therapeutics — phase, modality, and trial IDs.
- Programs
- 14
Quick answer
vTv Therapeutics has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Azeliragon
vTv Therapeutics
Alzheimer's Disease
1 trial -
Azeliragon 5mg
vTv Therapeutics
Alzheimer's Disease
1 trial -
Cadisegliatin 800 mg QD
vTv Therapeutics
Diabetes Mellitus, Type 1
1 trial -
Azeliragon
vTv Therapeutics
Alzheimer Disease
1 trial -
GK1-399 (formerly TTP399)
vTv Therapeutics
Type 2 Diabetes Mellitus
1 trial -
TTP054
vTv Therapeutics
Type 2 Diabetes Mellitus
1 trial -
TTP273
vTv Therapeutics
Type 2 Diabetes Mellitus
1 trial -
TTP399
vTv Therapeutics
Diabetes Mellitus, Type 1
1 trial -
TTP399 400 mg
vTv Therapeutics
Diabetes Mellitus, Type 2
1 trial -
TTP435
vTv Therapeutics
Obesity
1 trial -
TTP889
vTv Therapeutics
Venous Thromboembolism
1 trial -
TTP889
vTv Therapeutics
Coagulation
1 trial -
TTP4000
vTv Therapeutics
Alzheimer's Disease
1 trial -
TTP607
vTv Therapeutics
Advanced Cancers
1 trial
Frequently asked questions
How many pipeline programs does vTv Therapeutics have?
14 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs